Inve India ▾
NONOCIL

NOCIL Q3 FY25 results (Oct–Dec 2024) and concall

Chemicals · Concall AI · Call held 7 Feb 2025

NOCIL reported a challenging quarter marked by a sequential decline in both volume and revenue, primarily due to lower customer production and aggressive pricing from imports. This led to a significant compression in EBITDA margins to 8%. Management acknowledged the tough market conditions, driven by product dumping, and has initiated antidumping duty proceedings as a countermeasure. While expressing hope for a volume recovery, their tone on pricing has turned more cautious compared to previous quarters, indicating that near-term pressures are likely to persist.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25
Revenue363 318
EBITDA38 24
Net profit42 13
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.